z-logo
open-access-imgOpen Access
Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients
Author(s) -
Ahmet Çağkan İnkaya,
Emre Kara,
Nursel Çalık Başaran,
Taha Koray Şahin,
Oğuz Abdullah Uyaroğlu,
Ömrüm Uzun,
Serhat Ünal
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2102-84
Subject(s) - favipiravir , medicine , virology , covid-19 , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here